您的位置：
首页
>
农业专利
>
详情页
Compounds for the treatment of renal cell carcinoma
- 专利权人:
- MYROVLYTIS TECHNOLOGY VENTURES LIMITED
- 发明人:
- EAMONN MAHER,XIAOHONG LU
- 申请号：
- GB201216603
- 公开号：
- GB2491084A
- 申请日:
- 2011.02.17
- 申请国别(地区):
- GB
- 年份:
- 2012
- 代理人:
- 摘要：
- A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use in the treatment of renal cell carcinoma. In particular, the composition is suitable for use in the treatment of clear cell renal cell carcinoma. The composition is particularly useful for use in the treatment of renal cell carcinoma associated with Von Hippel-Lindau disease or Birt-Hogg-Dubé syndrome. A composition comprising mithramycin or a pharmaceutically acceptable salt or solvate thereof for use as a cytotoxic agent against FLCN-null or VHL-null renal cell carcinoma cells.
- 来源网站：
- 中国工程科技知识中心
- 来源网址：
- http://www.ckcest.cn/home/
